Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Budget 2023-24 Expectation: How India can attract investments and boost up forex reserves
- Technology Newsletter | May 2023
- Enhancing Agricultural Exports: Addressing Gaps in Marketing and Export Strategy for a State’s Largest Cooperative
- Program Management Support for the Prime Minister’s Flagship Fisheries Project to ensure broader implementation, good coordination and address implementation challenges
